David Siegel
About David Siegel
David Siegel serves as the Program Director for Biodefense Research at the National Institutes of Health, a position he has held since 2007. He has a medical degree from New York Medical College and has previously held significant roles at Loyola University Medical Center and Children's National Health System.
Work at National Institutes of Health
David Siegel has served as the Program Director for Biodefense Research at the National Institutes of Health (NIH) since 2007. In this role, he oversees research initiatives aimed at enhancing preparedness against biological threats. His work contributes to the development of strategies and solutions to address biodefense challenges. The NIH, located in Bethesda, Maryland, is a key institution in the United States for medical research and public health.
Education and Expertise
David Siegel earned his Doctor of Medicine degree from New York Medical College, where he studied from 1973 to 1976. He also holds a Bachelor of Science degree from Stony Brook University, which he completed prior to his medical training. His educational background provides a strong foundation in medicine and research, contributing to his expertise in biodefense.
Previous Positions in Healthcare
Before joining the NIH, David Siegel held significant roles in various healthcare institutions. He worked at Loyola University Medical Center as Vice Chairman for Administration and Pediatric Inpatient Director from 2006 to 2007. Prior to that, he served as an Attending Physician and Emergency Readiness Medical Care Coordinator at Children's National Health System from 1999 to 2006. These positions involved leadership and clinical responsibilities, enhancing his experience in pediatric care and emergency preparedness.
Career Timeline
David Siegel's career spans several decades in the medical field. He began his education at Stony Brook University, followed by his medical training at New York Medical College. After completing his studies, he gained experience in various roles, including his tenure at Children's National Health System and Loyola University Medical Center. Since 2007, he has been focused on biodefense research at the NIH, marking a significant phase in his professional journey.